CeriBell, Inc. (CBLL) Operating Margin
- Operating margin · 12 months: Value -68.62%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -68.62% | Operating income / revenue. Period ending 2026-06-30. $-69.97M ÷ $101.96M × 100 ≈ -68.62% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -69.97M USD | Operating Income (Loss) |
| Revenue | 101.96M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 22.95M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-69.97M | $101.96M | (m) | $22.95M | (m) | -68.62% |
| 2026-03-31 | $-64.94M | $95.07M | (m) | $21.06M | (m) | -68.31% |
| 2025-12-31 | $-58.40M | $89.06M | (m) | $19.14M | (m) | -65.57% |
| 2025-09-30 | $-56.69M | $82.81M | (m) | $17.99M | (m) | -68.46% |
| 2025-06-30 | $-51.98M | $77.42M | (m) | $16.41M | (m) | -67.14% |
| 2025-03-31 | $-45.46M | $71.53M | (m) | $14.82M | (m) | -63.55% |
| 2024-12-31 | $-39.71M | $65.44M | (m) | $13.56M | (m) | -60.68% |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $-30.04M | $45.23M | (m) | $8.99M | (m) | -66.43% |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |